Difficulty: Medium
Average Score: 89%
Practice
The pathophysiologic basis for antiparkinsonism therapy is:
Correct answer
A
Rationale
In the pathophysiology of Parkinson's disease, there is a selective loss of dopaminergic neurons in the substantia nigra of the brain. This loss leads to an imbalance between dopamine and acetylcholine, resulting in the characteristic motor symptoms of Parkinson's, such as tremors and rigidity.
Antiparkinsonism therapy aims to restore this dopamine-acetylcholine balance by increasing dopamine levels in the brain. Dopaminergic medications like levodopa are commonly used to alleviate symptoms. Therefore, option A, "A selective loss of dopaminergic neurons," is the correct answer as it directly addresses the underlying cause of Parkinson's disease.
The other options are incorrect because they do not align with the pathophysiology of Parkinson's disease. The loss of cholinergic, GABAergic, or glutamatergic neurons is not the primary pathological feature of Parkinson's disease and targeting these systems would not effectively address the motor symptoms associated with the condition.
Understanding the pathophysiological basis of antiparkinsonism therapy is crucial for healthcare professionals involved in managing patients with Parkinson's disease. By grasping the role of dopaminergic neurons in the disease process, healthcare providers can make informed decisions about treatment options and provide optimal care for individuals living with Parkinson's disease.
Antiparkinsonism therapy aims to restore this dopamine-acetylcholine balance by increasing dopamine levels in the brain. Dopaminergic medications like levodopa are commonly used to alleviate symptoms. Therefore, option A, "A selective loss of dopaminergic neurons," is the correct answer as it directly addresses the underlying cause of Parkinson's disease.
The other options are incorrect because they do not align with the pathophysiology of Parkinson's disease. The loss of cholinergic, GABAergic, or glutamatergic neurons is not the primary pathological feature of Parkinson's disease and targeting these systems would not effectively address the motor symptoms associated with the condition.
Understanding the pathophysiological basis of antiparkinsonism therapy is crucial for healthcare professionals involved in managing patients with Parkinson's disease. By grasping the role of dopaminergic neurons in the disease process, healthcare providers can make informed decisions about treatment options and provide optimal care for individuals living with Parkinson's disease.